Identification of β-endorphin, α-MSH and ACTH peptides in cultured human melanocytes, melanoma and squamous cell carcinoma cells by RP-HPLC

Experimental Dermatology

Volumn 7, Issue 4, 1998, Pages 213-216

  Slominski, A ^a  

^a LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERMEDIN; BETA ENDORPHIN; CORTICOTROPIN;

HORMONE DETERMINATION; HUMAN; LETTER; MELANOCYTE; MELANOMA; PEPTIDE ANALYSIS; PROTEIN DETERMINATION; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SKIN CARCINOMA; SQUAMOUS CELL CARCINOMA;

EID: 0031659948     PISSN: 09066705     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0625.1998.tb00326.x     Document Type: Letter

References (19)

1. 1 Luger T A., Scholzen T., Brzoska T., Becher E., Slominski A., Paus R. Cutaneous immunomodulation and coordination of skin stress responses by alpha‐melanocyte‐stimulating hormone. Ann NY Acad Sci 1998: in press.
2. 2 Winzen M., Yaar M., Burback J P H., Gilchrest B A.. Proopiomelanocortin gene product regulation in keratinocytes. J Invest Dermatol 1996: 106: 673–678.
3. 3 Slominski A., Paus R., Wortsman J. On the potential role of proopiomelanocortin in skin physiology and pathology. Mol Cell Endocrinol 1993: 93: C1–C6.
4. 4 Wakamatsu K., Graham A., Cook D., Thody A J.. Characterization of ACTH peptides in human skin and their activation of the melanocortin‐I receptor. Pigment Cell Res 1997: 10: 288–297.
5. 5 Smith A I., Funder J E.. Proopiomelanocortin processing in the pituitary, central nervous system, and peripheral tissues. Endocrine Rev 1988: 9: 159–179.
6. 6 Autelitano D J., Lundblad J R., Blum M., Roberts J L.. Hormonal regulation of POMC gene expression. Annu Rev Physiol 1989: 51: 715–726.
7. 7 Clark A L., Lavender P M., Besser G M., Rees L H.. Propiomelanocortin mRNA size heterogeneity in ACTH‐de‐pendent Cushing's syndrome. J Mol Endocrinol 1989: 2: 3–9.
8. 8 DeBold C R., Menefee J K., Nicholson W E., Orth D N.. Proopiomelanocortin gene is expressed in many normal human tissues and in tumors not associated with ectopic adrenocorticotropin syndrome. Mol Endocrinol 1988: 2: 862–870.
9. 9 Drouin J. et al. Tissue specific activity of the pro‐opiomelanocortin (POMC) gene and repression by glucorticoids. Genome 1989: 31: 510–519.
10. 10 Slominski A. POMC gene expression in hamster and mouse melanoma cells. FEBS Lett 1991: 291: 165–168.
11. 11 Schauer E. et al. Proopiomelanocortin‐derived peptides are synthesized and released by human keratinocytes. J Clin Invest 1994: 93: 2258–2262.
12. 12 Slominski A., Wortsman J., Mazurkiewicz J., Matsuoka L., Paus R., Lawrence K. Detection of the proopiomelanocortin‐derived antigens in normal and pathologic human skin. J Lab Clin Med 1993: 122: 658–666.
13. 13 Slominski A., Paus R., Mazurkiewicz J. Proopiomelanocortin expression in the skin during induced hair growth in mice. Experientia 1992: 48: 50–54.
14. 14 Furkert J. et al. Identification and measurement of β‐endorphin levels in the skin during induced hair growth in mice. Biochim Biophys Acta 1997: 1336: 315–322.
15. 15 Slominski A., Baker J., Ermak G., Chakraborty A., Pawelek J. UVB stimulates production of corticotropin releasing factor (CRF) by human melanocytes. FEBS Lett 1996: 399: 175–176.
16. 16 Slominski A., Ermak G., Mazurkiewicz J., Baker J., Wortsman J. Characterization of corticotropin‐releasing hormone (CRH) in human skin. J Clin Endocrin Metab 1998: 83: 1020–1024.
17. 17 Chakraborty A K. et al. Production and release of proopiomelanocortin (POMC) derived peptides by human melanocytes and keratinocytes in culture: regulation by Ultraviolet B. Biochim Biophys Acta 1996: 1313: 130–138.
18. 18 Slominski A., Mihm M C.. Potential mechanism of skin response to stress. Int J Dermatol 1996: 35: 849–851.
19. 19 Castro M G., Morrison E. Post‐translational processing of proopiomelanocortin in the pituitary and in the brain. Crit Rev Neurobiol 1997: 11: 35–57.